Premium listings
  • 3rd International Conference on Transcriptomics

    3rd International Conference on Transcriptomics

    Life Sciences Bangkok (Bangkok) March 13, 2017 Check with publisher

    Conference Series has been instrumental in conducting international Biochemistry meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Philadelphia, Orlando ...

  • Developing drugs for the treatment of neurodegenerative diseases

    Developing drugs for the treatment of neurodegenerative diseases

    PhD Studentships Liverpool December 3, 2016 Check with publisher

    Ageing is arguably the major biomedical challenge of the 21st century with the incidence of age-related diseases, and neurodegenerative diseases in particular, expected to increase dramatically in the coming decades. In model organisms, the process o...

  • DrugAge database of compounds that increase lifespan

    DrugAge database of compounds that increase lifespan

    Biomedical Sciences Liverpool August 24, 2015 Check with publisher

    We're starting a new database of drugs and compounds (including natural products) with anti-ageing properties that extend longevity in model organisms. The database will be called DrugAge, and although we have some data already, we are looking for da...

Listings
  • Clinical Data Management Seminar 2018

    Clinical Data Management Seminar 2018

    Clinical New Orleans (lousiana) July 5, 2018 1295.00 Dollar US$

    When new drugs or devices are tested in humans, the data generated by, and related to, these trials is known as clinical data. This data represents a huge investment by the biopharmaceutical or device company and is one of its greatest assets. It is ...

  • Verification vs Validation-Product, Equipment and QMS Software

    Verification vs Validation-Product, Equipment and QMS Software

    Drug Development Fremont (California) June 15, 2018 290.00 Dollar US$

    Overview: You will learn What do the U.S. FDA and EU Expect for Verification and Validation, Actions and documentation to meet U.S. FDA CGMP, ICH Q-series, and ISO 13485 expectations and requirements, ISO 14971 and IEC 62366 considerations, as approp...

  • Label Promotion of Drugs and Medical Devices 2018

    Label Promotion of Drugs and Medical Devices 2018

    Training and Teaching Fremont (California) April 19, 2018 Free

    Overview: This session sets the context for the off-label promotion of medical products starting with early history and moving to the most recent history of FDA's decision on guidance documents. Why should you Attend: This session will discuss commen...

  • Clinical Data Management - Benefits of Standardization in Establishing CDM Processes

    Clinical Data Management - Benefits of Standardization in Establishing CDM Processes

    Pharmacology - Drug Development Philadelphia (pennsylvania) April 2, 2018 Check with publisher

    Course "Clinical Data Management" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: When new drugs or devices are tested in humans, the data generated by, and re...

  • Promotion & Advertising Practices 2018 under FDA Observation

    Promotion & Advertising Practices 2018 under FDA Observation

    Medical - Health Philadelphia (pennsylvania) April 2, 2018 Check with publisher

    Course "FDA Scrutiny of Promotion and Advertising Practices" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: If you go "off label" with advertising and promoti...

  • Phase I Investigational Drug Products | USA Seminar 2018

    Phase I Investigational Drug Products | USA Seminar 2018

    Pharmacology - Drug Development Salt Lake city (Utah) April 2, 2018 Check with publisher

    Course "Different requirements for Phase I Investigational Drug Products: which GMPs apply since most Phase I drugs are exempt from full GMP requirements and what IND data requirements are necessary as a result?" has been pre-approved by RAPS as elig...

  • Expectations for Products Used in Early Phase

    Expectations for Products Used in Early Phase

    Drug Development Fremont (California) March 21, 2018 150.00 Dollar US$

    Overview: This presentation will review the GMP guidance document and discuss how it may be integrated with the recommendations of the guidance documents on CMC requirements. Areas Covered in the Session: Discussion of the elements found in the guida...

  • Fundamentals of Risk Management in Clinical Research 2018

    Fundamentals of Risk Management in Clinical Research 2018

    Quality Control, Safety & Security Fremont (California) March 21, 2018 150.00 Dollar US$

    Overview: The premise behind RBQM is that monitoring quality can be improved by leveraging existing data intelligence. This, in turn, calls for more robust quality assurance (QA) systems focused and efficient resource utilization and allocation at th...

  • GMP Regulations and How it Apply to Analytical Laboratories

    GMP Regulations and How it Apply to Analytical Laboratories

    Clinical Fremont (California) March 21, 2018 150.00 Dollar US$

    Overview: Auditing analytical laboratories can be complex because of the preparation that is often required. All of the GMP rules do not apply to the laboratory; while there may be additional requirements depending upon the type of testing that is be...

  • Drug Master Files and Quality Agreement Training Seminar 2018

    Drug Master Files and Quality Agreement Training Seminar 2018

    Drug Development Philadelphia (PA,PA) March 6, 2018 1495.00 Dollar US$

    Overview: This combined DMF (Drug Master Files) and Quality Agreement training will discuss the advantages for suppliers and drug product manufacturers in developing these arrangements together. Over time, there have been several misunderstandings be...

  • Label Promotion of Drugs and Medical Devices

    Label Promotion of Drugs and Medical Devices

    Training and Teaching Fremont (California) February 22, 2018 290.00 Dollar US$

    Overview: This session sets the context for the off-label promotion of medical products starting with early history and moving to the most recent history of FDA's decision on guidance documents. Why should you Attend: This class presents the latest F...

  • Discussion on Raw Material Methods and Specifications

    Discussion on Raw Material Methods and Specifications

    Medical Sciences Fremont (California) February 22, 2018 Check with publisher

    Overview: Based on knowledge of the active and inactive ingredient's function and role in the finished dosage form, Compendia methods and specifications are clearly accepted by third parties and regulatory agencies. Why should you Attend: The FDA has...